Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Video from France from a few days ago (there is a better way...) and a reminder of EU October date to have wastewater monitoring systems in place.
https://m.20minutes.fr/amp/a/3093011
Deepverge Aligned with EU COVID Wastewater Surveillance Approach
March 23, 2021
"Deepverge is focused on further development alongside partners such as the Aptamer Group, Tyndall Foundries and a number of undisclosed partners to investigate new variants of SARS-CoV-2 by adding a multiplex nano-chip to test for a range of infectious viruses and bacteria on a single chip for the MicrotoxPD range of equipment for detection and identification of SARS-CoV-2, E.coli, Legionella and Cryptosporidium. This will also add capability to our EcoWater OS platform where AI and real-time data analytics techniques will be applied to massive time-series databases to search and trends to allow better future predictability of the presence of “bad actors” in our water and wastewater networks, aligning with the Commission position that “An analysis of trends in results is also valuable for monitoring the effectiveness of measures put in place to curb virus transmission. Monitoring trends of viral concentration of SARS-CoV-2 variants in wastewater can therefore inform preparedness and response measures. It is therefore critical that Member States put in place effective wastewater surveillance systems ensuring that relevant data are promptly provided to competent health authorities.” "
https://www.modernwater.com/2021/03/23/deepverge-aligned-with-eu-covid-wastewater-surveillance-approach/
Some here like to overlook or totally discount the value of applying AI...
RNS Number : 2989P Deepverge PLC 17 February 2021
"8 Modern Water units being retrofitted with MicrotoxPD SARS-CoV-2 "
" 8 MW, Microtrace OVA, units are being retrofitted with the MicrotoxPD[v] real-time optofluidic COVID detection system for wastewater."
https://www.londonstockexchange.com/news-article/DVRG/prod-n-orders-worth-5m-for-modern-water-equipment/14867523
That should be more than enough so that further units are simply business as usual...
Page 8 of AGM report indicates as below:
"2021 Aug - Dec - Version 2 - 100+ units with motorised optical alignment"
https://www.deepverge.com/wp-content/uploads/2021/07/Deepverge-2021-AGM-Presentation.pdf
Euroboy, as trillsg says, a lot of the current PDs are retrofit into Microtox CTMs as part of pilots. Therefore it is unlikely that they would have been paid for and even if they had it would not have been financially significant enough to warrant an RNS.
The significance will come if and when they get a large/national contract and, as is being discussed elsewhere, they have put the resources in place to meet that future demand.
Euroboy, I don't think the initial MicrotoxPD's out in the field would have been purchased, they are giving us valuable data and proof they work. Just my thoughts.
Hey Euroboy............!
me 14:10 is quite a short read....... :)
All the best ('n sums up ya concerns IMO....... :()
Hi Chesh
Not sure if that quip re " peeps looking for a guarantee " is me being one of those peeps.
I'm not looking for a guarantee ... but I certainly wouldn't look a gift horse in the face either if one was being offered.
Having already lost a mighty sum on another share where the Company gave out RNS's saying all is fine, only to find the shares are now worthless (NMC Heathcare), shouldn't one be continually looking over their shoulder to make sure all is OK?
Since I'm on here, then I might as well say this too.
DV might be under NDA's, but that can't surely be including saying how much sales they've tied up in sales?
Yes they won't be able to say things to identify who the customer might be / where it is and similar, but the NDA won't stop them from saying "... contract signed for £x over y months" etc?
Paul the 4th..........!
you Sir should take this query on IMO......... :)
All the best (I'm somewhat bored of peeps looking for a guarantee ..... :()
Yes Ok individual sales are not enough to warrant an update of sales guidance, but if we have HAD sales and we ARE monitoring =, then they are ACTUAL sales.
If we HAVE enough of sites being monitored, then these are done / in the bag.
So you'd think sales should be way ahead of what the official guidance is wouldn't you.
But thanks for the replies.
Euroboy
Have enclosed copies of the 2 most recent RNS's re Sales:
17th February 2021 - China Orders - https://irpages2.equitystory.com/websites/rns_news/English/1100/news-tool---rns---eqs-group.html?iframe=true&article=31649681&company=Deepverge&iframe=true
11th January - 2021 guideline - https://irpages2.equitystory.com/websites/rns_news/English/1100/news-tool---rns---eqs-group.html?iframe=true&article=31561733&company=Deepverge&iframe=true
The CEO has confirmed in recent interviews that the 2021 revenue target of £10m is still the official target.
I read that an RNS should only be shared if revenues increase by 10% on previous reported figures (maybe incorrect), thats a bit squirly due to 'RNS reach' which some companies share like confetti. That said sales/contracts in DVRG maybe £100k per contract, do not facilitate an individual RNS but they may have 15 x £100k in a six month period.
The only way to RNS that (I guess) would be a Half Year Financial/Sales Update.
Any thoughts?
IMHO and FWIW
All the best with your investment
The £10m rev is guidance , an good guidance at that.........!
exponential growth in the AIM is rare, and you/we just may be in at the start of somefink....... :)
No need to update the guidance unless they have to, one of x2 multimillion (maybe x3) contracts for instance............ :()
All the best (Single entity (JV) with CR lands, I'd expect a revised guidance...... :)
Hi All
Has anyone got any notes of possible amount of sales that have taken place from the various hints / comments made here and there?
When is an RNS required in terms of expected sales differing from market expectations?
The expected sales put out by DV is £10M.
We believe there have been a number of sales, but won’t those sales have blown that estimate by now? That’s what all the Believers think right? If so, shouldn’t there be an RNS to say so?
I’m heavily invested from my point of view in what I hold in DV so I’m not trying to de-ramp … but looking for the upturn in published good news / upturn in SP.